Tracy Y. Wang is an Associate Professor of Medicine with Tenure in Cardiology at Duke University. An undergraduate of Yale University, she received her MD from Harvard Medical School and also holds an MSc degree in molecular biochemistry/ biophysics from Yale and an MHS degree in clinical research from Duke University. She joined the faculty at Duke University in 2008.
Dr. Wang is a health services researcher with expertise in implementation science and pragmatic clinical trials. She has led several cardiovascular clinical trials and registries at the Duke Clinical Research Institute (DCRI) that have focused on comparative effectiveness and safety, health disparities, care quality assessment and quality improvement. To date, she has published over 250 manuscripts on these topics. More recently, she has been the Principal Investigator of the ARTEMIS randomized clinical trial studying the impact of copayment reduction on antiplatelet medication adherence and outcomes after myocardial infarction. She has lectured widely on the use of “big data” to identify treatment gaps for intervention, and has led projects using data solutions to design and implement quality improvement initiatives. Additionally, she has been interested in evolving the platform for research to improve site and patient recruitment, innovate longitudinal patient follow-up, enrich the collection of patient-reported outcomes, pragmatically adjudicate clinical events of interest, and add important health economic insights.
Dr. Wang chaired the American Heart Association’s Quality of Care and Outcomes Research Council from 2017-2019, and serves on many tasks forces, committees, and writing groups for the American Heart Association, American College of Cardiology, and American College of Physicians. She is an Associate Editor of the JAMA Internal Medicine journal. She is the Director of Health Services and Outcomes Research at the DCRI. She remains a practicing noninvasive cardiologist with both inpatient and outpatient responsibilities.